Promestriene

DRUG4 trials

Sponsors

Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer, Hospices Civils de Lyon, Universidade Federal do Paraná, Federal University of São Paulo

Conditions

Breast CancerCervical cancerEndometrial HyperplasiaHypospadiasPelvic Organ ProlapseVaginal AtrophyVaginitis AtropicVulva; Atrophy

Phase 3

Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications

CompletedNCT01370798

Hospices Civils de LyonHypospadias

Start: 2011-05-26End: 2017-09-18Updated: 2025-09-04

Phase 4

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

CompletedNCT03032848

Universidade Federal do ParanáEndometrial Hyperplasia, Pelvic Organ Prolapse, Vaginitis Atropic

Start: 2013-11-26End: 2016-12-26Updated: 2019-05-01

Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer

Not yet recruitingCTIS2025-521460-36-00

Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I SunyerCervical cancer

Target: 120Updated: 2025-05-09

Unknown Phase

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

Active, not recruitingNCT04081805

Federal University of São PauloBreast Cancer, Vaginal Atrophy, Vulva; Atrophy

Start: 2019-09-30End: 2025-09-30Target: 195Updated: 2025-04-24

Related Papers

Clinical and histomorphometric evaluation of the vagina following treatment with CO<sub>2</sub> laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy.

2024-11-14

Abstract P4-07-34: CO2 laser, radiofrequency, and promestriene in treatment of genitourinary syndrome of menopause in breast cancer survivors. Clinical and histological aspects of a randomized control trial

Cancer Research2023-03-01